Patent · US Active

Morphic forms of complement factor D inhibitors

US11807627B2 · kind B2 · utility

4Cited by
63References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 25, 2019
Grant dateNov 7, 2023
Priority date—
Expiry dateOct 22, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides stable, highly crystalline forms of Complement Factor D inhibitor Compound 3 for therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.